Miudella (Sebela), a copper intrauterine device (IUD), has been approved by the FDA for prevention of pregnancy for up to 3 years. Miudella is the second copper IUD to be approved in the US; ParaGard, which contains more copper and is approved for up to 10 years of use, was approved in 1984. Four hormonal IUDs (Mirena, Liletta, Skyla, Kyleena) that release the progestin levonorgestrel are also available for pregnancy prevention (see Table 2).1
IUDs — IUDs are highly effective in preventing pregnancy....
ISSUE
The FDA has approved Shield (Guardant), a DNA blood test, for colorectal cancer (CRC) screening in average-risk adults ≥45 years old. Shield is the second blood-based DNA test to be approved for CRC screening; ColoHealth (formerly Epi proColon) was approved in 2016.1
COLORECTAL CANCER SCREENING ― Guidelines recommend screening average-risk adults for CRC beginning at age 45. Colonoscopy is generally the preferred method of screening; it can detect precancerous adenomas and allows for biopsy and removal of lesions during the procedure. Fecal immunochemical tests (FITs), which detect hemoglobin in stool, are often recommended for patients who are unwilling to undergo colonoscopy.2-5 Other alternatives include flexible sigmoidoscopy, computed tomography (CT) colonography, colon capsule endoscopy, multitarget stool DNA or RNA testing, and guaiac-based fecal occult …